State Street Corp Maia Biotechnology, Inc. Transaction History
State Street Corp
- $2.25 Trillion
- Q2 2024
A detailed history of State Street Corp transactions in Maia Biotechnology, Inc. stock. As of the latest transaction made, State Street Corp holds 34,400 shares of MAIA stock, worth $89,784. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,400
Previous 21,300
61.5%
Holding current value
$89,784
Previous $46,000
154.35%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MAIA
# of Institutions
22Shares Held
1.79MCall Options Held
0Put Options Held
0-
Halter Ferguson Financial Inc. Carmel, IN722KShares$1.88 Million1.75% of portfolio
-
Vanguard Group Inc Valley Forge, PA537KShares$1.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA157KShares$409,0960.0% of portfolio
-
Black Rock Inc. New York, NY78.5KShares$204,9390.0% of portfolio
-
Centric Wealth Management68.2KShares$177,9960.07% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $28.5M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...